[Silent myocardial ischemia. Arguments in favor of treatment].
Lezaun
R
R
Servicio de Cardiología, Hospital de Navarra, Pamplona.
Maraví
C
C
Gervás
H
H
Madariaga
I
I
Basterra
N
N
de los Arcos
E
E
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000787:Angina Pectoris / Q000175:diagnosis / Q000188:drug therapy; D000789:Angina, Unstable / Q000175:diagnosis / Q000188:drug therapy; D001262:Atenolol / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004562:Electrocardiography; D015716:Electrocardiography, Ambulatory; D006801:Humans; D009203:Myocardial Infarction / Q000150:complications; D017202:Myocardial Ischemia / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy*; D009204:Myocardial Revascularization; D011379:Prognosis; D011446:Prospective Studies; D013565:Sympatholytics / Q000627:therapeutic use; D013997:Time Factors
D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D013565:Sympatholytics; D001262:Atenolol
Isquemia miocárdica silente. Argumentos a favor de su tratamiento.